Medical technology specialist Medtronic has officially opened its new manufacturing facility in Singapore. The plant targets the anticipated demand growth for cardiac devices in Asia. Medtronic also plans to make Singapore its distribution hub for the Asia-Pacific region.
The government of Québec has established a new technology seed fund aimed at providing venture capital to start-up companies involved in life sciences. Projects must deal with research or development work taking place in Québec and must be related to life sciences.
Boehringer-Ingelheim has acquired the Fremont, Calif., facility of Amgen. The Fremont facility, which currently employs approximately 360, is a 100,000-sq.-ft. (9,290-sq.-m.) manufacturing facility with pilot plant and process development labs. Boehringer-Ingelheim has been a contract manufacturer for Amgen for more than a decade.
The 2011 World Congress on Industrial Biotechnology and Bioprocessing in Toronto May 9-11 will feature breakout sessions on investment potential. Industry analysts are projecting double-digit growth in the bio-based product sector.
St. Jude Medical has opened a technology center for physicians in Beijing, offering hands-on experience with new technologies and techniques. St. Jude Medical first entered the Chinese market in 1996. In the 15 years since, the China operation has grown from fewer than 10 employees to more than 250.
A recent study conducted by Rutgers University highlights the importance of the biopharma sector to New Jersey's economy. The industry provided more than 217,000 jobs in the state in 2009.
Thermo Fisher Scientific plans a new manufacturing facility in China within the Suzhou Science and Technology Town. It is part of the company's Asia expansion effort. The company already employs more than 1,400 in China.